The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis

Blood

Volumn 100, Issue 9, 2002, Pages 3068-3076

  Cragg, Mark S ^a,c   Claude Chan, H T ^a   Fox, Mathew D ^a   Tutt, Alison ^a   Smith, Aimée ^a   Oscier, David G ^b   Hamblin, Terry J ^b   Glennie, Martin J ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD79B ANTIGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN FC FRAGMENT; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; BURKITT LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0036839315     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.9.3068     Document Type: Article

References (42)

1. Reth M. Antigen receptors on B lymphocytes. Ann Rev Immunol. 1992;10:97-121.
2. Clark MR, Campbell KS, Kazlauskas A, et al. The B cell antigen receptor complex: Association of Igα and Igβ with distinct cytoplasmic effectors. Science. 1992;258:123-126.
3. Pleiman CM, D'Ambrosio D, Cambier JC. The B cell antigen receptor complex: Structure and signal transduction. Immunol Today. 1994;15:393-399.
4. Lin J, Justement L. The mb-1/b-29 heterodimer couples the B-cell antigen receptor to multiple src family PTK's. J Immunol. 1992;149:1548-1555.
5. Sanchez M, Misulovin Z, Burkhardt AL, et al. Signal transduction by immunoglobulin is mediated through Igα and Igβ. J Exp Med. 1993;178:1049-1055.
6. Hsueh RC, Scheuermann RH. Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor. Adv Immunol. 2000;75:283-316.
7. Tseng J, Eisfelder BJ, Clark MR. B-cell antigen receptor-induced apoptosis requires both Igα and Igβ. Blood. 1997;89:1513-1520.
8. Healy JI, Goodnow CC. Positive versus negative signaling by lymphocyte antigen receptors. Ann Rev Immunol. 1998;16:645-650.
9. Venkitaraman AR, Williams GT, Dariavach P, Neuberger MS. The B-cell antigen receptor of the five immunoglobulin classes. Nature. 1991;352:777-781.
10. Hashimoto S, Mohrenweiser HW, Gregersen PK, Chiorazzi N. Chromosomal localization, genomic structure, and allelic polymorphism of the human CD79 α (Ig-α/mb-1) gene. Immunogenetics. 1994;40:287-295.
11. Hashimoto S, Chiorazzi N, Gregersen PK. The complete sequence of the human CD79b (Ig β/B29) gene: Identification of a conserved exon/intron organization, immunoglobulin-like regulatory regions, and allelic polymorphism. Immunogenetics. 1994;40:145-149.
12. Rozman C, Montserrat E. Chronic lymphocytic leukemia, N Engl J Med. 1995;333:1052-1057.
13. Hamblin TJ, Oscier DG. Chronic lymphocytic leukaemia: The nature of the leukaemic cell. Blood Rev. 1997;11:119-128.
14. Hamblin TJ, Davies Z, Gardiner A, Oscier DO, Stevenson FK. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukaemia. Blood. 1999;94:1848-1854.
15. Lankester AC, Vancshijndel GMW, Vanderschoot CE, Vanoers MHJ, Vannoesel CJM, Vanlier RAW. Antigen receptor non-responsiveness in chronic lymphocytic leukaemia B-cells. Blood. 1995;86:1090-1097.
16. Zupo S, Isnardi L, Megna M, et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukaemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood. 1996;88:1365-1374.
17. Zomas AP, Matutes E, Morilla R, Owusus-Ankomah K, Seon BK, Catovsky D. Expression of the immunoglobulin associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukaemia. 1996;10:1966-1970.
18. Thompson AA, Talley JA, Do HN, et al. Aberrations of B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukaemia. Blood. 1997;90:1387-1394.
19. Alfarano A, Indraccolo S, Circosta P, et al. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia. Blood. 1999;93:2327-2335.
20. Hashimoto S, Chiorazzi N, Gregersen PK. Alternative splicing of CD79α (Ig-α/mb-1) and β (Ig-β/B29) RNA transcripts in human B cells. Mol Immunol. 1995;32:651-659.
21. Koyama M, Nakamura T, Higashihara M, et al. The novel variants of mb-1 and B29 transcripts generated by alternative splicing. Immunol Lett. 1995;47:151-156.
22. 3 antibody derivatives. In: Rees RC, Reynolds CW, eds. Tumour Immunobiology, A Practical Approach. Oxford, United Kingdom: Oxford University Press; 1993:225-244.
23. Zhang L, French RR, Chan HTC, et al. The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease. Ther Immunol. 1997;2:191-202.
24. Cragg MS, Asidipour A, O'Brien L, et al. Opposing properties of anti CD20 mAb. In: Mason D, Simmons D, Schwartz-Albiez R, Hadam M, Saalmuller A, Clark E, Malavasi F, Morrissey J, Vivier E, eds. Leukocyte Typing VII. Oxford, United Kingdom: Oxford University Press; 2002.
25. Seed B, Aruffo A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci U S A. 1987;84:3365-3369.
26. Dive C, Gregory CD, Phipps DJ, et al. Analysis and discrimination of necrosis and apoptosis by multiparameter flow cytometry. Biochem Biophys Acta. 1992;1133:275-285.
27. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: Flow cytometric detection of PS expression on early apoptotic cells using fluoroscein labelled annexin V. J Immunol Methods. 1995;184:39-51.
28. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271-279.
29. Cragg MS, Zhang L, French RR, Glennie MJ. Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells. Br J Cancer. 1999;79:850-857.
30. Verschuren MC, Conmans-Bitter WM, Kapteijn CA, et al. Transcription and protein expression of mb-1 and b29 genes in human hematopoietic malignancies and cell-lines. Leukaemia. 1993;7:1939-1947.
31. Rassenti LZ, Kipps TJ. Expression of Ig-β (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion. Blood. 2000;95:2725-2727.
32. Gordon MS, Kato RM, Lansigan F, Thompson AA, Wall R, Rawlings DJ. Aberrant B cell receptor signaling from B29 (Igβ, CD79b) gene mutations of chronic lymphocytic leukemia B cells. Proc Natl Acad Sci U S A. 2000;97:5504-5509.
33. Mason DY, Van Noesel CJ, Cordell JL, et al. B29 and mb-1 polypeptides are differentially expressed during B cell differentiation. Eur J Immunol. 1992;22:2753-2756.
34. Benlagha K, Guglielmi P, Cooper M-D, Lassoued K. Modification of Igα and Igβ expression as a function of B lineage differentiation. J Biol Chem. 1999;274:19389-19396.
35. Catovsky D. Current approach to the biology and treatment of chronic lymphoid malignancies other than CLL. Hematol Cell Ther. 1996;38(suppl 2):S63-S66.
36. Payelle-Brogard P, Magnac C, Mauro FR, Mandelli F, Dighiero G. Analysis of the B-cell receptor B29 (CD79b) gene in familial chronic lymphocytic leukemia. Blood. 1999;94:3516-3522.
37. Bell SE, Goodnow CC. A selective defect in IgM antigen receptor synthesis and transport causes loss of surface IgM expression on tolerant B lymphocytes. EMBO J. 1994;13:816-826.
38. Tanabe M, Sasai N, Nagata K, et al. The mammalian HSF4 gene generates both an activator and a repressor of heat shock genes by alternative splicing. J Biol Chem. 1999;274:27845-27856.
39. Jiang ZH, Wu JY. Alternative splicing and programmed cell death. Proc Soc Exp Bio Med. 1999;220:64-72.
40. Taylor JK, Zhang QQ, Wyatt JR, Dean NM. Induction of the endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Nat Biotechnol. 1999;17:1097-1100.
41. Love PE, Shores EW. ITAM multiplicity and thymocyte selection: How low can you go? Immunity. 2000;12:591-597.
42. Vilen BJ, Nakamura T, Cambier JC. Antigenstimulated dissociation of BCR mlg from Ig-α/Ig-β: Implications for receptor desensitization. Immunity. 1999;10:239-248.